Gideon Koren, MD, FRCPC, FACMT
- 9Articles
- 63.3KReads
- 2005–2015Active
- 45Collaborators
- 1.1KCitations
About
Gideon Koren, MD, FRCPC, FACMT, has published extensively on the effects of psychotropic drug exposure during pregnancy, with a focus on maternal depression, antidepressant use, and perinatal outcomes. His work addresses neurodevelopmental outcomes in children prenatally exposed to selective serotonin reuptake inhibitors and investigates the association between antidepressant exposure and congenital malformations. He has also studied the impact of maternal morbidity, atypical antipsychotic drugs, and specific medications such as duloxetine and mirtazapine on pregnancy and neonatal adaptation. His research spans topics in depression, neurology, seizures, and women's health.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
